Leelyn Smith, LLC Charles River Laboratories International, Inc. Transaction History

Leelyn Smith, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$204.13 - $302.4 $56,339 - $83,462	276 Added 100.0%	552 $118,000
Q1 2021 May 05, 2021	SELL	$249.67 - $299.48 $6,241 - $7,487	-25 Reduced 8.31%	276 $80,000
Q4 2020 Jan 15, 2021	BUY	$222.0 - $252.62 $9,990 - $11,367	45 Added 17.58%	301 $75,000
Q3 2020 Nov 05, 2020	SELL	$175.56 - $226.45 $6,144 - $7,925	-35 Reduced 12.03%	256 $58,000
Q2 2020 Aug 06, 2020	SELL	$118.84 - $189.72 $3,921 - $6,260	-33 Reduced 10.19%	291 $51,000
Q1 2020 May 06, 2020	BUY	$98.9 - $178.34 $32,043 - $57,782	324 New	324 $41,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

Stay updated on Leelyn Smith, LLC with notifications on news.